Literature DB >> 34343507

Syndrome of Nonobstructive Coronary Artery Diseases: A Comprehensive Overview of Open Artery Ischemia.

Lina Ya'qoub1, Islam Y Elgendy2, Carl J Pepine3.   

Abstract

Syndromes of cardiac ischemia with nonobstructive coronary arteries have been increasingly recognized as a clinical entity with heterogeneous clinical presentations, commonly encountered in women. Knowledge of pathophysiology and clinical risk factors is key to ensuring appropriate diagnostic evaluation and management for these often-neglected patients. In this review, we discuss the epidemiology, risk factors, and clinical presentations of these syndromes. We provide algorithms for diagnosis and management of these entities based on current scientific knowledge and highlight some of the key knowledge gaps and ongoing trials in this emerging field.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angina; Coronary microvascular dysfunction; Ischemia; Myocardial infarction with nonobstructive coronary arteries; Nonobstructive coronary artery disease; Vasospastic angina

Mesh:

Substances:

Year:  2021        PMID: 34343507      PMCID: PMC8754003          DOI: 10.1016/j.amjmed.2021.06.038

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  56 in total

1.  Low Incidence of Diabetes Mellitus in Coronary Microvascular Dysfunction: An Intriguing Association.

Authors:  Lovely Chhabra; N Gurukripa Kowlgi
Journal:  JACC Cardiovasc Interv       Date:  2016-01-06       Impact factor: 11.195

Review 2.  Requiem for the 'vulnerable plaque'.

Authors:  Peter Libby; Gerard Pasterkamp
Journal:  Eur Heart J       Date:  2015-07-22       Impact factor: 29.983

3.  An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

Authors:  Matheen A Khuddus; Carl J Pepine; Eileen M Handberg; C Noel Bairey Merz; George Sopko; Anthony A Bavry; Scott J Denardo; Susan P McGorray; Karen M Smith; Barry L Sharaf; Steven J Nicholls; Steven E Nissen; R David Anderson
Journal:  J Interv Cardiol       Date:  2010-10-04       Impact factor: 2.279

4.  Initial Invasive or Conservative Strategy for Stable Coronary Disease.

Authors:  David J Maron; Judith S Hochman; Harmony R Reynolds; Sripal Bangalore; Sean M O'Brien; William E Boden; Bernard R Chaitman; Roxy Senior; Jose López-Sendón; Karen P Alexander; Renato D Lopes; Leslee J Shaw; Jeffrey S Berger; Jonathan D Newman; Mandeep S Sidhu; Shaun G Goodman; Witold Ruzyllo; Gilbert Gosselin; Aldo P Maggioni; Harvey D White; Balram Bhargava; James K Min; G B John Mancini; Daniel S Berman; Michael H Picard; Raymond Y Kwong; Ziad A Ali; Daniel B Mark; John A Spertus; Mangalath N Krishnan; Ahmed Elghamaz; Nagaraja Moorthy; Whady A Hueb; Marcin Demkow; Kreton Mavromatis; Olga Bockeria; Jesus Peteiro; Todd D Miller; Hanna Szwed; Rolf Doerr; Matyas Keltai; Joseph B Selvanayagam; P Gabriel Steg; Claes Held; Shun Kohsaka; Stavroula Mavromichalis; Ruth Kirby; Neal O Jeffries; Frank E Harrell; Frank W Rockhold; Samuel Broderick; T Bruce Ferguson; David O Williams; Robert A Harrington; Gregg W Stone; Yves Rosenberg
Journal:  N Engl J Med       Date:  2020-03-30       Impact factor: 91.245

5.  Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac Syndrome X: role of superoxide dismutase activity.

Authors:  Carmine Pizzi; Olivia Manfrini; Fiorella Fontana; Raffaele Bugiardini
Journal:  Circulation       Date:  2003-12-29       Impact factor: 29.690

6.  Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes.

Authors:  Rajesh Garg; Ajay D Rao; Maria Baimas-George; Shelley Hurwitz; Courtney Foster; Ravi V Shah; Michael Jerosch-Herold; Raymond Y Kwong; Marcelo F Di Carli; Gail K Adler
Journal:  Diabetes       Date:  2014-08-14       Impact factor: 9.461

7.  Myocardial Infarction With Nonobstructive Coronary Arteries: A Call for Individualized Treatment.

Authors:  Debabrata Mukherjee
Journal:  J Am Heart Assoc       Date:  2019-07-09       Impact factor: 5.501

8.  An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group.

Authors:  Vijay Kunadian; Alaide Chieffo; Paolo G Camici; Colin Berry; Javier Escaned; Angela H E M Maas; Eva Prescott; Nicole Karam; Yolande Appelman; Chiara Fraccaro; Gill Louise Buchanan; Stéphane Manzo-Silberman; Rasha Al-Lamee; Evelyn Regar; Alexandra Lansky; J Dawn Abbott; Lina Badimon; Dirk J Duncker; Roxana Mehran; Davide Capodanno; Andreas Baumbach
Journal:  EuroIntervention       Date:  2021-01-20       Impact factor: 6.534

9.  Systemic microvascular dysfunction in microvascular and vasospastic angina.

Authors:  Thomas J Ford; Paul Rocchiccioli; Richard Good; Margaret McEntegart; Hany Eteiba; Stuart Watkins; Aadil Shaukat; Mitchell Lindsay; Keith Robertson; Stuart Hood; Eric Yii; Novalia Sidik; Adam Harvey; Augusto C Montezano; Elisabeth Beattie; Laura Haddow; Keith G Oldroyd; Rhian M Touyz; Colin Berry
Journal:  Eur Heart J       Date:  2018-12-07       Impact factor: 29.983

Review 10.  Guidelines for the management of myocardial infarction/injury with non-obstructive coronary arteries (MINOCA): a position paper from the Dutch ACS working group.

Authors:  T F S Pustjens; Y Appelman; P Damman; J M Ten Berg; J W Jukema; R J de Winter; W R P Agema; M L J van der Wielen; F Arslan; S Rasoul; A W J van 't Hof
Journal:  Neth Heart J       Date:  2020-03       Impact factor: 2.380

View more
  2 in total

Review 1.  Coronary Microvascular Dysfunction in Patients with Non-Obstructive Coronary Arteries: Current Gaps and Future Directions.

Authors:  Islam Y Elgendy; Lina Ya'Qoub; Kuan-Han Chen; Carl J Pepine
Journal:  Drugs       Date:  2022-01-29       Impact factor: 9.546

Review 2.  Non-obstructive Plaque and Treatment of INOCA: More to Be Learned.

Authors:  Lina Ya'Qoub; Islam Y Elgendy; Carl J Pepine
Journal:  Curr Atheroscler Rep       Date:  2022-07-04       Impact factor: 5.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.